Neuron-specific phosphorylation of mitogen- and stress-activated protein kinase-1 involved in cerebral hypoxic preconditioning of mice

Journal of Neuroscience Research

Volumn 85, Issue 6, 2007, Pages 1279-1287

  Huang, Ping ^a   Qi, Zhifeng ^a   Bu, Xiangning ^a   Zhang, Nan ^a   Han, Song ^a   Fang, Li ^b   Li, Junfa ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Brain; Ischemic hypoxic preconditioning (I HPC); Mitogen and stress activated protein kinase 1 (MSK1); Phosphorylation; Protein expression

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROGRANIN; SERINE; STRESS ACTIVATED PROTEIN KINASE 1; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; HYPOXIA, BRAIN; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; MALE; MICE; MICE, INBRED BALB C; NEUROGRANIN; NEURONS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SERINE; THREONINE; TIME FACTORS;

EID: 34248168662     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21242     Document Type: Article

References (52)

1. Arthur JS, Cohen P. 2000. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482:44-48.
2. Arthur JS, Fong AL, Dwyer JM, Davare M, Reese E, Obrietan K, Impey S. 2004. Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins. J Neurosci 24:4324-4332.
3. 2+ -dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg 103:419-429 [table].
4. Blaschke F, Stawowy P, Goetze S, Hintz O, Grafe M, Kintscher U, Fleck E, Graf K. 2002. Hypoxia activates beta(1)-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun 296:890-896.
5. 2+/CaM in the activation of MAPK and p38 gamma. Adv Exp Med Biol 475:293-302.
6. Das S, Tosaki A, Bagchi D, Maulik N, Das DK. 2006. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/ cAMP response element-binding protein signaling. J Pharmacol Exp Ther 317:980-988.
7. Deak M, Clifton AD, Lucocq LM, Alessi DR. 1998. Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/ p38, and may mediate activation of CREB. EMBO J 17:4426-4441.
8. Duncan EA, Anest V, Cogswell P, Baldwin AS. 2006. The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser10 phosphorylation. J Biol Chem 281:12521-12525.
9. Dunn KL, Espino PS, Drobic B, He S, Davie JR. 2005. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83:1-14.
10. Dyson MH, Thomson S, Inagaki M, Goto H, Arthur SJ, Nightingale K, Iborra FJ, Mahadevan LC. 2005. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen-and stress-activated kinase 1/2. J Cell Sci 118:2247-2259.
11. Emerson MR, Samson FE, Pazdernik TL. 2000. Effects of hypoxia preconditioning on expression of metallothionein-1,2 and heme oxygenase-1 before and after kainic acid-induced seizures. Cell Mol Biol 46:619-626.
12. Frodin M, Jensen CJ, Merienne K, Gammeltoft S. 2000. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 19:2924-2934.
13. Gao Y, Gao G, Long C, Han S, Zu P, Fang L, Li J. 2006. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem Biophys Res Commun 340:661-667.
14. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. 2006. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596.
15. Gu Z, Jiang Q, Zhang G. 2001. Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport 12:3487-3491.
16. Huang KP, Huang FL, Jager T, Li J, Reymann KG, Balschun D. 2004. Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. J Neurosci 24:10660-10669.
17. Hughes JP, Staton PC, Wilkinson MG, Strijbos PJ, Skaper SD, Arthur JS, Reith AD. 2003. Mitogen and stress response kinase-1 (MSK1) mediates excitotoxic induced death of hippocampal neurones. J Neurochem 86:25-32.
18. Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA. 2000. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 77:65-75.
19. Jones NM, Bergeron M. 2001. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 21:1105-1114.
20. Kefaloyianni E, Gaitanaki C, Beis I. 2006. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal (in press).
21. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. 2005. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19:2026-2028.
22. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K. 1990. "Ischemic tolerance" phenomenon found in the brain. Brain Res 528:21-24.
23. Lee CW, Nam JS, Park YK, Choi HK, Lee JH, Kim NH, Cho J, Song DK, Suh HW, Lee J, Kim YH, Huh SO. 2003. Lysophosphatidic acid stimulates CREB through mitogen- and stress-activated protein kinase-1. Biochem Biophys Res Commun 305:455-461.
24. Li J, Pak JH, Huang FL, Huang KP. 1999. N-methyl-D-aspartate induces neurogranin/RC3 oxidation in rat brain slices. J Biol Chem 274:1294-1300.
25. Li J, Huang FL, Huang KP. 2001. Glutathiolation of proteins by glutathione disulfide S-oxide derived from S-nitrosoglutathione. Modifications of rat brain neurogranm/RC3 and neuromodulin/GAP-43. J Biol Chem 276:3098-3105.
26. Li J, Niu C, Han S, Zu P, Li H, Xu Q, Fang L. 2005. Identification of protein kinase C isoforms involved in cerebral hypoxic preconditioning of mice. Brain Res 1060:62-72.
27. Li J, Yang C, Han S, Zu P, Wu J, Xu Q, Fang L. 2006. Increased phosphorylation of neurogranm in the brain of hypoxic preconditioned mice. Neurosci Lett 391:150-153.
28. Liu X, Xu F, Fu Y, Liu F, Sun S, Wu X. 2006. Calreticulin induces delayed cardioprotection through mitogen-activated protein kinases. Proteomics 6:3792-3800.
29. Long C, Gao Y, Gao G, Han S, Zu P, Fang L, Li J. 2006. Decreased phosphorylation and protein expression of ERK1/2 in the brain of hypoxic preconditioned mice. Neurosci Lett 397:307-312.
30. Lonze BE, Ginty DD. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623.
31. McCoy CE, Campbell DG, Deak M, Bloomberg GB, Arthur JS. 2005. MSK1 activity is controlled by multiple phosphorylation sites. Biochem J 387:507-517.
32. Mishra OP, Ashraf QM, Delivoria-Papadopoulos M. 2002. Phosphorylation of cAMP response element binding (CREB) protein during hypoxia in cerebral cortex of newborn piglets and the effect of nitric oxide synthase inhibition. Neuroscience 115:985-991.
33. Mishra OP, Zubrow AB, Ashraf QM. 2004. Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neuroscience 123:179-186.
34. Murry CE, Jennings RB, Reimer KA. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
35. Neuner-Jehle M, Denizot JP, Mallet J. 1996. Neurogranin is locally concentrated in rat cortical and hippocampal neurons. Brain Res 733:149-154.
36. New L, Zhao M, Li Y, Bassett WW, Feng Y, Ludwig S, Padova FD, Gram H, Han J. 1999. Cloning and characterization of RLPK, a novel RSK-related protein kinase. J Biol Chem 274:1026-1032.
37. Niu C, Li J, Cui X, Han S, Zu P, Li H, Xu Q. 2005. Changes in cPKC isoform-specific membrane translocation and protein expression in the brain of hypoxic preconditioned mice. Neurosci Lett 384:1-6.
38. Pak JH, Huang FL, Li J, Balschun D, Reymann KG, Chiang C, Westphal H, Huang KP. 2000. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc Natl Acad Sci USA 97:11232-11237.
39. Piao CS, Yu YM, Han PL, Lee JK. 2003. Dynamic expression of p38beta MAPK in neurons and astrocytes after transient focal ischemia. Brain Res 976:120-124.
40. Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W. 1998. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38 alphaMAPK). J Biol Chem 273:29661-29671.
41. Raklut S, Clark CJ, O'Shaughnessy CT, Morris BJ. 2005. N-methyl-D-aspartate and brain-derived neurotrophic factor induce distinct profiles of extracellular signal-regulated kinase, mitogen- and stress-activated kinase, and ribosomal s6 kinase phosphorylation in cortical neurons. Mol Pharmacol 67:1158-1165.
42. Rubino A, Yellon DM. 2000. Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? Trends Pharmacol Sci 21:225-230.
43. Sato M, Cordis GA, Maulik N, Das DK. 2000. SAPKs regulation of ischemic preconditioning. Am J Physiol Heart Circ Physiol 279:H901-H907.
44. Schiller M, Bohm M, Dennler S, Ehrchen JM, Mauviel A. 2006. Mitogen-and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes. Oncogene 25: 4449-4457.
45. Schuck S, Soloaga A, Schratt G, Arthur JS, Nordheim A. 2003. The kinase MSK1 is required for induction of c-fos by lysophosphatidic acid in mouse embryonic stem cells. BMC Mol Biol 4:6.
46. Smith KJ, Carter PS, Bridges A, Horrocks P, Lewis C, Pettman G, Clarke A, Brown M, Hughes J, Wilkinson M, Bax B, Reith A. 2004. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein. Structure 12:1067-1077.
47. Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, Mahadevan LC, Arthur JS. 2003. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J 22:2788-2797.
48. 2-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice. Neurosci Lett 294:117-120.
49. Webber KM, Smith MA, Lee HG, Harris PL, Moreira P, Perry G, Zhu X. 2005. Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease. J Neurosci Res 79:554-560.
50. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 22:2871-2881.
51. Wu J, Li J, Huang KP, Huang FL. 2002. Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse. J Biol Chem 277:19498-19505.
52. 2+/calmodulin-dependent neuronal signaling in the hippocampus. J Neurochem 86:1524-1533.